MedPath

Comparison between efficiency of artificial bone particles with specialized human blood clot and artificial bone particles with liquified human blood clot in the treatment of bony defects in severe gum disease

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/09/046101
Lead Sponsor
Dr Sayali Gotpagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients diagnosed with Chronic Periodontitis.

2)Patients who are non smokers or do not consume tobacco in any other form.

3)Patients are in good systemic health with no contraindication to periodontal surgery.

4)Patients having pocket depths >5mm, intraosseous defects > 3mm and with radiographic

evidence of vertical / angular bone loss in the affected sites.

5)Involved teeth to be vital and asymptomatic.

Exclusion Criteria

1) One-walled osseous defects.

2) Patients suffering from any systemic diseases or with a compromised immune system.

3) Patients who had received any type of periodontal therapy for the past 6 months.

4) Patients taking immunosuppressant drugs like corticosteroids.

5) Patients with a known history of allergy to Doxycycline or Chlorhexidine or any other

medicine used in the study.

6) Patients showing unacceptable oral hygiene compliance during / after Phase I

periodontal therapy.

7) Patients taking any drug known to cause gingival enlargement.

8) Pregnant and/or lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath